These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24116074)

  • 1. Activation of STAT3 in human gastric cancer cells via interleukin (IL)-6-type cytokine signaling correlates with clinical implications.
    Wang Z; Si X; Xu A; Meng X; Gao S; Qi Y; Zhu L; Li T; Li W; Dong L
    PLoS One; 2013; 8(10):e75788. PubMed ID: 24116074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer.
    Zhu BH; Chen HY; Zhan WH; Wang CY; Cai SR; Wang Z; Zhang CH; He YL
    World J Gastroenterol; 2011 May; 17(18):2315-25. PubMed ID: 21633597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmented gp130-mediated cytokine signalling accompanies human gastric cancer progression.
    Jackson CB; Judd LM; Menheniott TR; Kronborg I; Dow C; Yeomans ND; Boussioutas A; Robb L; Giraud AS
    J Pathol; 2007 Oct; 213(2):140-51. PubMed ID: 17724739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [(-)-Epigallocatechin-3-gallate reduces vascular endothelial growth factor expression in gastric cancer cells via suppressing activity].
    Zhu BH; He YL; Zhan WH; Cai SR; Wang Z; Zhang CH; Chen HY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Aug; 14(8):631-5. PubMed ID: 21866460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
    Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
    Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Constitutive activation and clinical significance of Stat3 in human gastric cancer tissues and cell lines].
    Yu LF; Zhu YB; Qiao MM; Zhong J; Tu SP; Wu YL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2064-9. PubMed ID: 15730617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma.
    Yin Y; Si X; Gao Y; Gao L; Wang J
    Oncol Rep; 2013 Jan; 29(1):34-8. PubMed ID: 23117246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
    Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
    Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of CD44v6 expression in gastric carcinoma by the IL-6/STAT3 signaling pathway and its clinical significance.
    Xu YY; Guo M; Yang LQ; Zhou F; Yu C; Wang A; Pang TH; Wu HY; Zou XP; Zhang WJ; Wang L; Xu GF; Huang Q
    Oncotarget; 2017 Jul; 8(28):45848-45861. PubMed ID: 28507278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
    Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer.
    Dalwadi H; Krysan K; Heuze-Vourc'h N; Dohadwala M; Elashoff D; Sharma S; Cacalano N; Lichtenstein A; Dubinett S
    Clin Cancer Res; 2005 Nov; 11(21):7674-82. PubMed ID: 16278387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragalus extract inhibits proliferation but enhances apoptosis in gastric cancer.
    Wang Z; Dong L; Zhen Y; Wang Y; Qi D; Xu A; Meng X; Li W
    Pak J Pharm Sci; 2016 Sep; 29(5):1473-1482. PubMed ID: 27731799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially localized survivin and STAT3 as markers of gastric cancer progression: Association with Helicobacter pylori.
    Pandey A; Tripathi SC; Shukla S; Mahata S; Vishnoi K; Misra SP; Misra V; Mitra S; Dwivedi M; Bharti AC
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1004. PubMed ID: 32729225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway.
    Xu X; Yang C; Chen J; Liu J; Li P; Shi Y; Yu P
    Biochem Biophys Res Commun; 2018 May; 499(2):273-278. PubMed ID: 29574157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice.
    Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ
    J Clin Invest; 2008 May; 118(5):1727-38. PubMed ID: 18431520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
    Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the IL-11/STAT3 signaling pathway in human chronic atrophic gastritis and gastric cancer.
    Wang DQ; Ding XP; Yin S; Mao YD
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZIPK activates the IL-6/STAT3 signaling pathway and promotes cisplatin resistance in gastric cancer cells.
    Fan H; Ou Q; Su Q; Li G; Deng Z; Huang X; Bi J
    FEBS Open Bio; 2021 Sep; 11(9):2655-2667. PubMed ID: 34375503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.